100G误码仪
Search documents
半导体测试设备“体检师”IPO注册生效,联讯仪器专利诉讼、财务风险待解
Xin Lang Cai Jing· 2026-02-03 12:53
Group 1 - The core viewpoint of the article is that Suzhou Lianxun Instrument Co., Ltd. has made significant progress towards the capital market with its IPO registration effective on January 29, focusing on high-end electronic measurement and semiconductor testing equipment, and is expected to turn a profit in 2024 [3][34]. - Lianxun Instrument has established itself as the third-largest player in the electronic measurement instrument market in China, with a strong focus on high-speed optical communication testing [4][35]. - The company has experienced rapid growth in revenue, with figures increasing from 214 million yuan in 2022 to 806 million yuan in the first nine months of 2025, and is projected to achieve profitability in 2024 [10][42]. Group 2 - The electronic measurement instruments produced by Lianxun include communication testing instruments and electrical performance testing instruments, which are widely used in communication and semiconductor fields [5][38]. - The semiconductor testing equipment segment includes optoelectronic device testing equipment, power device testing equipment, and electrical performance testing equipment [8][40]. - The company has a significant market opportunity due to the digitalization and intelligent transformation of China's manufacturing industry, with the electronic measurement instrument market expected to grow from 23.85 billion yuan in 2020 to 35.38 billion yuan in 2024, at a CAGR of 10.4% [4][36]. Group 3 - Lianxun Instrument has faced challenges, including ongoing patent infringement lawsuits and high accounts receivable and inventory levels, which have raised concerns about cash flow and financial management [4][24]. - The company has reported a rapid increase in accounts receivable, with balances rising from 896.3 million yuan in 2022 to 400 million yuan in 2025, indicating potential issues with customer payment cycles [25][57]. - The company has also seen a significant increase in its R&D personnel, growing from 110 in 2022 to 440 by September 2025, reflecting its commitment to innovation and product development [15][48].